These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 22371525)
1. Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial. Lyngå P; Persson H; Hägg-Martinell A; Hägglund E; Hagerman I; Langius-Eklöf A; Rosenqvist M Eur J Heart Fail; 2012 Apr; 14(4):438-44. PubMed ID: 22371525 [TBL] [Abstract][Full Text] [Related]
2. Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study. Dendale P; De Keulenaer G; Troisfontaines P; Weytjens C; Mullens W; Elegeert I; Ector B; Houbrechts M; Willekens K; Hansen D Eur J Heart Fail; 2012 Mar; 14(3):333-40. PubMed ID: 22045925 [TBL] [Abstract][Full Text] [Related]
3. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. Koehler F; Winkler S; Schieber M; Sechtem U; Stangl K; Böhm M; Boll H; Kim SS; Koehler K; Lücke S; Honold M; Heinze P; Schweizer T; Braecklein M; Kirwan BA; Gelbrich G; Anker SD; Eur J Heart Fail; 2010 Dec; 12(12):1354-62. PubMed ID: 21098580 [TBL] [Abstract][Full Text] [Related]
4. Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trial. Boyne JJ; Vrijhoef HJ; Crijns HJ; De Weerd G; Kragten J; Gorgels AP; Eur J Heart Fail; 2012 Jul; 14(7):791-801. PubMed ID: 22588319 [TBL] [Abstract][Full Text] [Related]
5. Telephone support to rural and remote patients with heart failure: the Chronic Heart Failure Assessment by Telephone (CHAT) study. Krum H; Forbes A; Yallop J; Driscoll A; Croucher J; Chan B; Clark R; Davidson P; Huynh L; Kasper EK; Hunt D; Egan H; Stewart S; Piterman L; Tonkin A Cardiovasc Ther; 2013 Aug; 31(4):230-7. PubMed ID: 23061492 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of Renin-Angiotensin-aldosterone blockade for heart failure in presence of preserved left ventricular function. Meune C; Wahbi K; Duboc D; Weber S J Cardiovasc Pharmacol Ther; 2011; 16(3-4):368-75. PubMed ID: 21193681 [TBL] [Abstract][Full Text] [Related]
7. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study). Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751 [TBL] [Abstract][Full Text] [Related]
8. Impact of telemedical care and monitoring on morbidity in mild to moderate chronic heart failure. Morguet AJ; Kühnelt P; Kallel A; Jaster M; Schultheiss HP Cardiology; 2008; 111(2):134-9. PubMed ID: 18376125 [TBL] [Abstract][Full Text] [Related]
9. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. Frazier CG; Alexander KP; Newby LK; Anderson S; Iverson E; Packer M; Cohn J; Goldstein S; Douglas PS J Am Coll Cardiol; 2007 Apr; 49(13):1450-8. PubMed ID: 17397674 [TBL] [Abstract][Full Text] [Related]
10. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Deswal A; Bozkurt B Am J Cardiol; 2006 Apr; 97(8):1228-31. PubMed ID: 16616031 [TBL] [Abstract][Full Text] [Related]
11. [Home-based telemonitoring of simple vital signs to reduce hospitalization in heart failure patients: real-world data from a community-based hospital]. Palmieri V; Pezzullo S; Lubrano V; Bettella S; Olandese M; Sorrentino C; Russo C; Celentano A G Ital Cardiol (Rome); 2011 Dec; 12(12):829-36. PubMed ID: 22158454 [TBL] [Abstract][Full Text] [Related]
12. Long-term results after a telephone intervention in chronic heart failure: DIAL (Randomized Trial of Phone Intervention in Chronic Heart Failure) follow-up. Ferrante D; Varini S; Macchia A; Soifer S; Badra R; Nul D; Grancelli H; Doval H; J Am Coll Cardiol; 2010 Jul; 56(5):372-8. PubMed ID: 20650358 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Goldberg LR; Piette JD; Walsh MN; Frank TA; Jaski BE; Smith AL; Rodriguez R; Mancini DM; Hopton LA; Orav EJ; Loh E; Am Heart J; 2003 Oct; 146(4):705-12. PubMed ID: 14564327 [TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction. Wang NC; Piccini JP; Konstam MA; Maggioni AP; Traver B; Swedberg K; Udelson JE; Zannad F; Cook T; O'Connor CM; Miller AB; Grinfeld L; Gheorghiade M; Am J Ther; 2010; 17(4):e78-87. PubMed ID: 20634650 [TBL] [Abstract][Full Text] [Related]
15. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial. Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J; Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365 [TBL] [Abstract][Full Text] [Related]
16. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827 [TBL] [Abstract][Full Text] [Related]
17. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867 [TBL] [Abstract][Full Text] [Related]
18. Failure of benefit and early hazard of bucindolol for Class IV heart failure. Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ; J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547 [TBL] [Abstract][Full Text] [Related]
19. The relationship between mitral regurgitation and ejection fraction as predictors for the prognosis of patients with heart failure. Pecini R; Thune JJ; Torp-Pedersen C; Hassager C; Køber L Eur J Heart Fail; 2011 Oct; 13(10):1121-5. PubMed ID: 21865237 [TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]